Ozempic maker Novo Nordisk buys Athlone drug plant in $92m deal

Novo Nordisk, the Danish healthcare firm behind the so-called “miracle drugs” Ozempic and Wegovy, has bought a drug manufacturing plant in Athlone which it will use in its plans for global expansion.

The firm has entered into a definitive agreement with Alkermes, the Irish head-quartered pharma firm and the current owners of the former Elan Drug Technologies plant, worth $92.5 million (€85 million).

The two companies plan to enter into subcontracting arrangements to continue certain ...